Your browser doesn't support javascript.
loading
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Vogelzang, Nicholas J; Olsen, Mark R; McFarlane, Joshua J; Arrowsmith, Edward; Bauer, Todd M; Jain, Rohit K; Somer, Bradley; Lam, Elaine T; Kochenderfer, Mark D; Molina, Ana; Doshi, Gurjyot; Lingerfelt, Brian; Hauke, Ralph J; Gunuganti, Vijay; Schnadig, Ian; Van Veldhuizen, Peter; Fleming, Mark; Galamaga, Robert; Gupta, Mukul; Hool, Hugo; Hutson, Thomas; Zhang, Joshua; McHenry, M Brent; Johansen, Jennifer L; Tykodi, Scott S.
Afiliación
  • Vogelzang NJ; US Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV. Electronic address: Nicholas.Vogelzang@usoncology.com.
  • Olsen MR; Medical Oncology, Oklahoma Cancer Specialists, Tulsa, OK.
  • McFarlane JJ; Hematology/Oncology, Virginia Cancer Institute, Richmond, VA.
  • Arrowsmith E; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Chattanooga, TN.
  • Bauer TM; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN.
  • Jain RK; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
  • Somer B; Medical Oncology, The West Clinic, Memphis, TN.
  • Lam ET; Medical Oncology, University of Colorado Cancer Center, Aurora, CO.
  • Kochenderfer MD; Hematology and Medical Oncology, Blue Ridge Cancer Care, Roanoke, VA.
  • Molina A; Department of Medicine, Weill Cornell Medicine, New York, NY.
  • Doshi G; Texas Oncology, US Oncology Research, Houston, TX.
  • Lingerfelt B; Department of Medical Oncology and Hematology, Charleston Oncology, Charleston, SC.
  • Hauke RJ; Nebraska Cancer Specialists, Omaha, NE.
  • Gunuganti V; Department of Oncology, Cancer Care Centers of South Texas, San Antonio, TX.
  • Schnadig I; Compass Oncology, Tigard, OR.
  • Van Veldhuizen P; Department of Medical Oncology, Research Medical Center, Kansas City, MO.
  • Fleming M; Virginia Oncology Associates, US Oncology Research, Norfolk, VA.
  • Galamaga R; Department of Hematology/Oncology Illinois Cancer Specialists, Niles, IL.
  • Gupta M; Department of Medical Oncology and Hematology, Sansum Clinic, Santa Barbara, CA.
  • Hool H; Department of Oncology and Hematology, Torrance Memorial Medical Center, Torrance, CA.
  • Hutson T; Texas Oncology, Baylor Charles A. Sammons Cancer Center, Dallas, TX.
  • Zhang J; Bristol Myers Squibb, Princeton, NJ.
  • McHenry MB; Bristol Myers Squibb, Princeton, NJ.
  • Johansen JL; Bristol Myers Squibb, Princeton, NJ.
  • Tykodi SS; Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Clin Genitourin Cancer ; 18(6): 461-468.e3, 2020 12.
Article en En | MEDLINE | ID: mdl-32718906
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article